Ventricular PKC-ε and humoral signaling in DOCA-salt rats treated with labedipinedilol-A

Drug Development Research

Volumn 59, Issue 3, 2003, Pages 307-315

  Yeh, Jwu Lai ^a   Liang, Jyh Chong ^a   Liou, Shwu Fen ^a   Lin, Young Tso ^a   Sheu, Sheng Hsiung ^b   Lai, Wen Ter ^b   Shin, Shyi Jang ^b   Chen, Ing Jun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ANP; Antihypertensive therapy; DOCA salt; ET 1; Protein kinase C

Indexed keywords

ADRENERGIC RECEPTOR; AMLODIPINE; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM CHANNEL; DEOXYCORTICOSTERONE ACETATE; LABEDIPINEDILOL A; LABETALOL; NIFEDIPINE; PRAZOSIN; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DRUG URINE LEVEL; HEART WEIGHT; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; TACHYCARDIA;

EID: 0041624590     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10214     Document Type: Article

References (42)

1. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. 1990. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67:1355-1364.
2. 2+ channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol 31:2191-2197.
3. Chien KB, Knowlton KU, Zhu H, Chien S. 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5:3037-3046.
4. Clozel JP, Kuhn H, Hefti F. 1989. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 7:267-275.
5. Fareh J, Touyz RM, Schiffrin EL, Thibault G. 2000. Altered cardiac endothelin receptors and protein kinase C in deoxycorticosteronesalt hypertensive rats. J Mol Cell Cardiol 32:665-676.
6. Frishman WH, Glasser S, Stone P, Deedwania PC, Johnson M, Fakouhi TD. 1999. Comparison of controlled-onset, extended-release verpamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Am J Cardiol 83:507-514.
7. Frohlich ED. 1983. Hemodynamics and other determinants in development of left ventricular hypertrophy. Fed Proc 42: 2709-2715.
8. Gu X, Bishop SP. 1994. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 75:926-9314.
9. Ito H. 1997. Endothelins and cardiac hypertrophy. Life Sci 61: 585-593.
10. Ito H, Hirata Y, Hiroe M. 1991. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69:209-215.
11. Ito H, Hirata Y, Adachi S. 1993. Endothelin is an autocrine-paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92:398-403.
12. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 89:21.98-2203.
13. Jones LG, Rozich JD, Tsutsui H, Cooper G. 1992. Endothelin stimulates multiple responses in isolated adult ventricular cardiac myocytes. Am J Physiol 263:H1447-1454.
14. Kaplan NM. 1996. The calcium channel blocker controversy. Hypertens Res 19:57-64.
15. Karam H, Heudes D, Hess P, Gonzales M, Loffler B, Clozel M, Clozel J. 1996. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats Cardiovasc Res 31:287-295.
16. Kira Y, Nakaoka T, Hashimoto E, Okabe F, Asano S, Seldne I. 1994. Effect of long-term cyclic mechanical load on protein synthesis and morphological changes in cultured myocardial cells from neonatal rat. Cardiovasc Drug Ther 8:251-262.
17. Larivière R, Thibault G, Schiffrin EL. 1993. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 21:294-300.
18. Lee YJ, Shin SJ, Tan MS, Hsieh TJ, Tsai JH. 1996. Increase renal atrial naturetic peptide synthesis in rats with deoxycorticosterone acetate salt treatment. Am J Physiol 271:F779-789.
19. Liang JC, Yeh JL, Chiang LC, Yang YC, Sheu SH, Lai WT, Chen IJ. 2000. Labedipinedilol-A: a vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long-acting antihypertensive properties. Drug Dev Res 49:94-108.
20. Liang JC, Yeh JL, Wang CS, Liou SF, Tsai CH, Chen IJ. 2002. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display α/β-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorgan Med Chem 10:719-730.
21. Miyamori I, Matsubara T, Takeda Y, Koshida H, Soma R, Takeda R. 1990. Angiotensin II generation in mesenteric arteries in rats: effects of nephrectomy, deoxycorticosterone and dexamethasone. Endocr J 37:9-17.
22. Nakamaru M, Jackson EK, Inagami T. 1986. Adrenoreceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol 250:H144-148.
23. Naurse M, Tanabe A, Sekii T, Adachi C, Yoshimoto T, Mishina N, Imaki T, Naruse K, Demura R, Demura H. 1999. Effects of two calcium channel blockers on messenger RNA expression of endothelin-1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats. J Hypertens 17:53-60.
24. Nishizuka Y. 1992, Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-613.
25. Ohlstein EH, Arleth AJ, Storer B, Romanic AM. 1998. Carvediol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells. J Mol Cell Cardiol 30:167-173.
26. Puceat M, Vassort G. 1996. Signalling by protein kinase C isoforms in the heart. Mol Cell Biochem 157:65-72.
27. Ruzicka M, Yuan B, Harmsen E, Leenen FHH. 1993. The rennin-angiotensin system and volume overload-induced cardiac hypertrophy in rats: effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 87:921-930.
28. Schenk J, McNeill JH. 1992. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Met 27:161-170.
29. Steinberg SF, Goldberg M, Rybin VO. 1995. Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 27:141-153.
30. Suzuki T, Kumazaki T, Mitsui Y. 1993. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191:823-830.
31. Tikkanen T, Tikkanen I, Fyhrquist F. 1987. Plasma atrial natriuretic peptide in DOCA-NaCl-treated rats. Acta Physiol Scand 129: 151-155.
32. Touyz RM, Fareh J, Thibault G, Schiffrin EL. 1998. Endothelin-1 signaling is altered in cardiac cells from deoxycorticosterone acetate-salt hypertensive rats. J Cardiovasc Pharmacol 31(Suppl 1):S179-181.
33. Tsoporis J, Leenen FH. 1988. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension 11:376-386.
34. Ueno Y, Mohara O, Brosnihan KB, Ferrario CM. 1988. Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension. Hypertension 11(Suppl I): 172-177.
35. Vandenburgh HH, Solerssi R, Shansky J, Adams JW, Henderson SA, Lemaire J. 1995. Response of neonatal rat cardiomyocytes to repetitive mechanical stimulation in vitro. Ann NY Acad Sci 752:19-29.
36. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. 1988. Collagen remodeling of the pressure-overload, hypertrophied nonhuman primate myocardium. Circ Res 62: 757-765.
37. Weinstock M, Schorer-Apelbaum D, Ben-Ishay D. 1984. Baroreflex sensitivity and susceptibility to systolic hypertension induced by DOCA-salt in the Sabra rat. Am J Physiol 246:H448-452.
38. Yamamoto J, Tsuchia M, Saito M, Ikeda M. 1985. Cardiac contractile and coronary flow reserves in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 7:569-577.
39. Yamazaki T, Komuro I, Yazaki Y. 1999. Role of the rennin-angiotensin system in cardiac hypertrophy. Am J Cardiol 83:H53-57.
40. Yasunobu H, Hiroaki M, Etsu S, Hiroshi H, Tokuichiro S, Yuzuru M, Yoshikazu M, Kenji K, Naoto M, Hisayuki M, Tsuneaki S. 1993. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats: effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Circulation 87:554-561.
41. Yeh JL, Liou SF, Liang JC, Huang YC, Chiang LC, Wu JR, Lin YT, Chen IJ. 2000. Vanidipinedilol: a vanilloid-based β-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities. J Cardiovasc Pharmacol 35:51-63.
42. Yeh JL, Tsai CH, Liang JC, Wu JR, Huang YC, Chen IJ. 2001. Third-generation dihydropyridine-type calcium channel blocker labedipinedilol-B displaying α/β-adrenoceptor blocking activities. Drug Dev Res 52:462-474.